KFG
RPRX icon

Kingdom Financial Group’s Royalty Pharma RPRX Stock Holding History

Kingdom Financial Group’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.6K Buy
+492
New +$25.6K 0.01% 330
2026
Q1 		– Sell
-436
Closed -$16.8K – 918
2025
Q4 		$16.8K Buy
+436
New +$16.6K 0.01% 367

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kingdom Financial Group's RPRX Position: Q2 2026 in Review

Kingdom Financial Group opened a new position in Royalty Pharma (RPRX) in Q2 2026: 492 shares worth $27.6K. The stake represents 0.01% of the portfolio and ranks #330 among its holdings. This is a return to the name: Kingdom Financial Group previously reported a position in RPRX as recently as Q4 2025.

Kingdom Financial Group first reported a position in RPRX in Q4 2025 and has held it in 2 quarters since. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Kingdom Financial Group held 492 shares of Royalty Pharma worth $27.6K as of Q2 2026.
  • Royalty Pharma was a new Kingdom Financial Group position in Q2 2026.
  • Royalty Pharma made up 0.01% of Kingdom Financial Group's portfolio in Q2 2026, its #330 holding.
  • Kingdom Financial Group first reported a position in Royalty Pharma in Q4 2025 and has held it in 2 quarters since.
  • 646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Kingdom Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.